retatrutide trial dosing just posted the biggest weight-loss numbers ever recorded for a drug — 28.3% (≈70 lb) average in Phase 3, with 45% of people hitting 30%+ loss, territory once reserved for bariatric retatrutide clinical trial dosing frequency

Facing increasing revenue pressures, the state expects to save $17 million per year from the move

Which product type segment is expected to dominate the GLP-1 Companion Products Market

GLP-1 therapies are being produced at extremely high volumes, often requiring multiple dedicated production lines and multi-year commitments

Fresh fruit, with the exception of citrus, tends to be stomach friendly as well

We were quite excited by the findings, as this study was the first to demonstrate a physiological role of GLP-1 in appetite control and energy intake in humans

American Board of Pediatrics (ABP) Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.50 MOC points in the American Board of Pediatrics (ABP) Maintenance of Certification (MOC) program